2,747 research outputs found
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease
Non-alcoholic fatty liver disease (NAFLD) has recently been recognized as the leading cause of the abnormalities in the liver function tests in the Western countries. Celiac disease (CD) is a permanent immunological intolerance to gluten proteins in genetically predisposed individuals. CD has been reported in 4-13 % of the cases with steatohepatitis, although the pathogenesis of the liver steatosis in CD patients is unclear. Based on the literature data, it can be concluded that the inclusion of serological markers of CD should be a part of the general workup in the patients with steatosis when other causes of the liver disease are excluded and in the patients with NAFLD when metabolic risk factors are not evident
Linseed Oil as a Source of Polyunsaturated Fatty Acids in Broiler Chicken Nutrition
The aim of the paper was to examine the effect of polyunsaturated fatty acids from linseed oil on productive performances and fatty acid composition of lipids of broiler chicken abdominal fat, as well as correlation and regression between consumed amount of oil and possibilities of their incorporation in the tissues. For the need of experimental research, three groups of 40 day old chicken, hybrid line Cobb 500 were formed. Every group had five replicates, in total amount of 200 chickens per treatment. Control group were fed with diet in addition of 4% soybean oil, while the experimental groups were fed with addition of 4 and 8% of linseed oil in the diet. Addition of linseed oil had a statistically high (P<0.01) influence on chicken body weight reduction in treatments T2 and T3, compared to the body weights of chicken in control group T1. Feed conversion ratio in chicken in experimental groups T2 and T3 was 1.84 and 1.82 kg of feed/kg of gain. Introduction of linseed oil in amounts of 4 and 8% in chicken nutrition led to statistically high (P<0.01) differences in content of linoleic acid (C18:2) in treatments T2 and T3, compared to control group T1, which leads to a conclusion that linseed oil significantly reduces linoleic acid in tissue. Compared to linoleic acid, content of α-linolenic acid (C18:3) was statistically significantly increased (P<0.05) in treatment T2 and highly significantly (P<0.01) in treatment T3, compared to control. Negative values of regression (b) and correlation (r) also confirm the fact that introduction of linseed oil in the diet significantly reduces content of linoleic acid in fat tissue of chickens (b=-0.551; r=-0.79), while the same coefficients show positive dependence between added linseed oil in the diet and deposited linolenic acid in tissues (b=1.081 and r=0.87). Based on the gained results it can be concluded that addition of linseed oil in the amount of 4 and 8% could be successfully used in chicken nutrition for fatty acid composition improvement and for lowering the ratio between n-6/n-3 polyunsaturated fatty acid in tissues of broilers
Exacerbations and lung function decline in COPD: New insights in current and ex-smokers
SummaryAimTo investigate whether there is a significant relationship between an increased frequency of exacerbations and the rate of forced expiratory volume in 1s (FEV1) decline in COPD patients.Methods–measurementsAbout 102 COPD patients (44 smokers, 58 ex-smokers) participated in a 3-year prospective study. Exacerbations were identified as worsening of patient's respiratory symptoms as recorded on diary cards. Spirometry was performed every 6 months. The effect of frequent exacerbations on lung function was investigated using random effects models.ResultsThe median (mean(95% CI)) annual exacerbation rate was 2.85 (3.1 (2.7–3.6)). Patients with an annual exacerbation rate over the median rate had significantly lower baseline post-bronchodilation FEV1(%pred), higher MRC dyspnoea score and chronic cough compared to patients who had an annual exacerbation rate less than the median. The average annual rate of FEV1(%pred), adjusted for smoking decline (ΔFEV1), was found significantly increased in frequent compared to infrequent exacerbators (P=0.017). The highest ΔFEV1 was observed in smokers frequent exacerbators and a significant interaction between exacerbation frequency and ΔFEV1 was also observed in ex-smokers.ConclusionsOur findings suggest that an increased frequency of exacerbations is significantly associated with FEV1 decline even in ex-smokers. Thus, smoking and frequent exacerbations may have both negative impact on lung function. Smoking cessation and prevention of exacerbations should be a major target in COPD
Radiomics-Based Assessment of Primary Sjögren's Syndrome From Salivary Gland Ultrasonography Images
Salivary gland ultrasonography (SGUS) has shown good potential in the diagnosis of primary Sjögren's syndrome (pSS). However, a series of international studies have reported needs for improvements of the existing pSS scoring procedures in terms of inter/intra observer reliability before being established as standardized diagnostic tools. The present study aims to solve this problem by employing radiomics features and artificial intelligence (AI) algorithms to make the pSS scoring more objective and faster compared to human expert scoring. The assessment of AI algorithms was performed on a two-centric cohort, which included 600 SGUS images (150 patients) annotated using the original SGUS scoring system proposed in 1992 for pSS. For each image, we extracted 907 histogram-based and descriptive statistics features from segmented salivary glands. Optimal feature subsets were found using the genetic algorithm based wrapper approach. Among the considered algorithms (seven classifiers and five regressors), the best preforming was the multilayer perceptron (MLP) classifier (κ = 0.7). The MLP over-performed average score achieved by the clinicians (κ = 0.67) by the considerable margin, whereas its reliability was on the level of human intra-observer variability (κ = 0.71). The presented findings indicate that the continuously increasing HarmonicSS cohort will enable further advancements in AI-based pSS scoring methods by SGUS. In turn, this may establish SGUS as an effective noninvasive pSS diagnostic tool, with the final goal to supplement current diagnostic tests
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure
Introduction: Understanding the intersection of HIV, aging and health is crucial due to the increasing number of people aging with HIV. Objective: The objective of the study was to assess the prevalence of, and risk factors for individual comorbidities and multi-morbidity in people living with HIV with similar duration of HIV infection, notwithstanding a 25-year difference at the time of HIV acquisition. Methods: In a cross-sectional multicentre retrospective study, we compared three match-control age groups. The "Young" were selected from Romania and included HIV-positive patients prenatally infected and assessed at the age of 25-30 years. The "Old" and the "Geriatric" were selected from Italy. These respectively included subjects infected with HIV at the age of 25 years and assessed at the age of 50-55 years, and those infected at the age of 50 years and assessed at the age of 75-80 years. Each group was sex and age matched in a 1: 5 ratio with controls selected from the CINECA ARNO database from Italy. We described non-infectious comorbidities (NICM), including cardiovascular disease, hypertension, dyslipidaemia, diabetes, chronic kidney disease, and multi-morbidity (MM >= 3 NICM). Results: MM prevalence in the "Young" group compared to controls was 6.2% vs 0%, while in the "Geriatric" was "68.2% vs 3.6%. Using "Young" as a reference, in multivariate analyses, predictors for MM were as follows: HIV serostatus (OR=47.75, IQR 14.78-154.25, p<0.01) and "Geriatric" vs "Young" (OR=30.32, IQR 5.89-155.98, p<0.01). Conclusion: These data suggest that age at acquisition of HIV should be considered as a risk factor for NICM and MM
PERFORMANCE OF MACRO DIVERSITY WIRELESS COMMUNICATION SYSTEM OPERATING IN WEIBUL MULTIPATH FADING ENVIRONMENT
In this paper, we consider wireless mobile radio communication system with macro diversity reception. Signal is subject to Weibull small scale fading and Gamma large scale fading resulting in system performance degradation. Receiver uses macro diversity selection combining (SC) technique in order to reduce the impact of long term fading effects, and two micro diversity SC branches are used to mitigate Weibull short term fading effects on system performance. Probability density function (PDF), and cumulative distribution function (CDF), as well as level crossing rate (LCR) and average fade duration (AFD) of the SC receiver output signal envelope are evaluated. The obtained expressions converge rapidly for all considered values of Weibull fading parameter and Gamma shadowing severity parameter. Mathematical results are studied in order to analyze the influence of Weibull fading parameter and Gamma shadowing severity parameter on statistical properties of the SC receiver output signal
Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action
Mastiha is a natural nutritional supplement with known anti-inflammatory properties. Non-alcoholic fatty liver disease (NAFLD) and Inflammatory bowel disease (IBD) are immune mediated inflammatory diseases that share common pathophysiological features. Mastiha has shown beneficial effects in both diseases. MicroRNAs have emerged as key regulators of inflammation and their modulation by phytochemicals have been extensively studied over the last years. Therefore, the aim of this study was to investigate whether a common route exists in the anti-inflammatory activity of Mastiha, specifically through the regulation of miRNA levels. Plasma miR-16, miR-21 and miR-155 were measured by Real-Time PCR before and after two double blinded and placebo-controlled randomized clinical trials with Mastiha. In IBD and particularly in ulcerative colitis patients in relapse, miR-155 increased in the placebo group (p = 0.054) whereas this increase was prevented by Mastiha. The mean changes were different in the two groups even after adjusting for age, sex and BMI (p = 0.024 for IBD and p = 0.042). Although the results were not so prominent in NAFLD, miR-155 displayed a downward trend in the placebo group (p = 0.054) whereas the levels did not changed significantly in the Mastiha group in patients with less advanced fibrosis. Our results propose a regulatory role for Mastiha in circulating levels of miR-155, a critical player in T helper-17 (Th17) differentiation and function
- …